Seres Therapeutics, Inc. Share Price

Seres Therapeutics, Inc. Share Price

NASDAQ: MCRB | Micro Cap
$2.01
-$0.01 (-0.5%) Last updated on 07 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Seres Therapeutics, Inc. Stock Performance

Open
$2.12
Prev. Close
$2.02
Circuit Range
N/A
Day Range
$2.02 - $2.23
Year Range
$1.68 - $29.59
Volume
3,805
Average Traded
$2.15

Seres Therapeutics, Inc. Share Price Today

As of 8 November 2026, Seres Therapeutics, Inc.'s share price is $2.01. The stock opened at $2.12, compared to its previous close of $2.02. During today's trading session, Seres Therapeutics, Inc.'s share price traded between $2.02 and $2.23, with an average price of $2.13. Over the past 52 weeks, the stock has recorded a high of $29.59 and a low of $1.68. In terms of performance, Seres Therapeutics, Inc.'s share price has declined by 72.73% over the last six months and is down 88.86% on a year-on-year basis.

Seres Therapeutics, Inc. Share Price Chart

Line chart of the Seres Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 2.01 to 2.23, ending at 2.01.
$2.02$2.23
L
Show Current Price
H

Seres Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$17.81M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.61
Revenue (TTM)
$790.00M
Return On Equity (TTM)
-219.83%
Profit Margin
721.52%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-6.19%

Seres Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.44$0.36$0.74$0.59
Net Profit-$15.34-$19.91$4.58-$16.29
Net Profit Margin-3486.36%-5530.56%618.92%-2761.02%
Income ChangeN/A-29.79%123.00%-455.68%

Seres Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.79
Net Profit-$250.16-$113.72$0.14$5.70
Net Profit MarginN/AN/AN/A721.52%
Income ChangeN/A54.54%100.12%3971.43%

About Seres Therapeutics, Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Seres Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.87
$2.02
+14.77%
Oct 2026
$3.19
$1.76
-47.77%
Sep 2026
$4.96
$3.37
-32.33%
Aug 2026
$4.97
$4.98
+5.06%
Jul 2026
$7.76
$4.74
-39.85%
Jun 2026
$7.39
$7.88
+6.92%
May 2026
$7.45
$7.37
-0.81%
Apr 2026
$9.20
$7.43
-16.52%
Mar 2026
$8.89
$8.90
+1.71%
Feb 2026
$15.00
$8.75
-40.58%
Jan 2026
$14.99
$14.72
-0.77%
Dec 2025
$18.05
$14.84
-17.74%

MCRB Share Price FAQs